KYTX
Kyverna Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.85
−0.68%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-92.2%
Return on equity
-69.4%
Return on assets
-80.0%
Return on invested capital
0.00x
Asset turnover
-$158.8M
Cash from operations
$3.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026